Extendicare Inc.
EXETF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.50 | 0.08 | -0.46 | 0.23 |
| FCF Yield | 4.22% | 3.28% | 0.27% | 0.44% |
| EV / EBITDA | 29.21 | 25.85 | 40.25 | 26.83 |
| Quality | ||||
| ROIC | 5.18% | 5.05% | 4.79% | 5.08% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 2.65 | 1.66 | 1.23 | 0.88 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.91% | 6.43% | 5.91% | 6.27% |
| Free Cash Flow Growth | 37.25% | 1,209.69% | -26.97% | -87.57% |
| Safety | ||||
| Net Debt / EBITDA | 3.48 | 3.90 | 5.54 | 4.15 |
| Interest Coverage | 8.01 | 7.15 | 5.70 | 5.26 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 18.15 | 22.72 | 21.90 | 21.22 |